These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 7499498)
1. Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice. Liuzzi GM; Riccio P; Dal Canto MC J Neuroimmunol; 1995 Oct; 62(1):91-102. PubMed ID: 7499498 [TBL] [Abstract][Full Text] [Related]
2. Effect of Theiler's murine encephalomyelitis virus and cytokines on cultured oligodendrocytes and astrocytes. Qi Y; Dal Canto MC J Neurosci Res; 1996 Aug; 45(4):364-74. PubMed ID: 8872896 [TBL] [Abstract][Full Text] [Related]
3. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. Zheng L; Calenoff MA; Dal Canto MC J Neuroimmunol; 2001 Aug; 118(2):256-67. PubMed ID: 11498260 [TBL] [Abstract][Full Text] [Related]
4. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291 [TBL] [Abstract][Full Text] [Related]
5. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. Miller SD; Gerety SJ; Kennedy MK; Peterson JD; Trotter JL; Tuohy VK; Waltenbaugh C; Dal Canto MC; Lipton HL J Neuroimmunol; 1990 Jan; 26(1):9-23. PubMed ID: 1688446 [TBL] [Abstract][Full Text] [Related]
6. A hybrid between a resistant and a susceptible strain of mouse alters the pattern of Theiler's murine encephalomyelitis virus-induced white matter disease and favors oligodendrocyte-mediated remyelination. Dal Canto MC; Melvold RW; Kim BS Mult Scler; 1995 Jun; 1(2):95-103. PubMed ID: 9345459 [TBL] [Abstract][Full Text] [Related]
7. Lymphocytes from mice chronically infected with Theiler's murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein. Epitope spreading in TMEV infection has functional activity. Dal Canto MC; Calenoff MA; Miller SD; Vanderlugt CL J Neuroimmunol; 2000 Apr; 104(1):79-84. PubMed ID: 10683517 [TBL] [Abstract][Full Text] [Related]
8. Viral hyperinfection of the central nervous system and high mortality after hematopoietic stem cell transplantation for treatment of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Burt RK; Padilla J; Dal Canto MC; Miller SD Blood; 1999 Oct; 94(8):2915-22. PubMed ID: 10515897 [TBL] [Abstract][Full Text] [Related]
9. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. Gerety SJ; Rundell MK; Dal Canto MC; Miller SD J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740 [TBL] [Abstract][Full Text] [Related]
10. IFNγ influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease. Bowen JL; Olson JK Viral Immunol; 2013 Aug; 26(4):223-38. PubMed ID: 23829778 [TBL] [Abstract][Full Text] [Related]
12. Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus. Jin YH; Mohindru M; Kang MH; Fuller AC; Kang B; Gallo D; Kim BS J Virol; 2007 Nov; 81(21):11690-702. PubMed ID: 17715222 [TBL] [Abstract][Full Text] [Related]
14. Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease. Li L; Ulrich R; Baumgärtner W; Gerhauser I J Neuroinflammation; 2015 Dec; 12():242. PubMed ID: 26703877 [TBL] [Abstract][Full Text] [Related]
15. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice. Gerety SJ; Clatch RJ; Lipton HL; Goswami RG; Rundell MK; Miller SD J Immunol; 1991 Apr; 146(7):2401-8. PubMed ID: 1706400 [TBL] [Abstract][Full Text] [Related]
16. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Dal Canto MC; Melvold RW; Kim BS; Miller SD Microsc Res Tech; 1995 Oct; 32(3):215-29. PubMed ID: 8527856 [TBL] [Abstract][Full Text] [Related]
17. The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Jin YH; Kang HS; Hou W; Meng L; Kim BS J Virol; 2015 Feb; 89(3):1867-78. PubMed ID: 25428872 [TBL] [Abstract][Full Text] [Related]
18. Central nervous system Toll-like receptor expression in response to Theiler's murine encephalomyelitis virus-induced demyelination disease in resistant and susceptible mouse strains. Turrin NP Virol J; 2008 Dec; 5():154. PubMed ID: 19094215 [TBL] [Abstract][Full Text] [Related]
19. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. Clatch RJ; Lipton HL; Miller SD J Immunol; 1986 Feb; 136(3):920-7. PubMed ID: 2416841 [TBL] [Abstract][Full Text] [Related]
20. The role of interleukin-6 in the expression of PD-1 and PDL-1 on central nervous system cells following infection with Theiler's murine encephalomyelitis virus. Jin YH; Hou W; Kang HS; Koh CS; Kim BS J Virol; 2013 Nov; 87(21):11538-51. PubMed ID: 23966393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]